Tauriga Sciences Inc. Chief Executive Officer Reports Additional Insider Purchases "Open Market" Exceeding 3,500,000 Shares Since August 01, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK, Sept. 4, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG) ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license agreements and evaluating potentially lucrative acquisition targets in an industry agnostic manner, has today announced that its Chief Executive Officer ("CEO"), Mr. Seth M. Shaw ("Mr. Shaw"), has completed an additional series of insider purchases (open market) that have exceeded 3,500,000 shares since August 01, 2013. These shares have been purchased at a price range between $0.0175 and $0.03 per share, with corresponding Form 4(s) having been filed at the appropriate times to disclose the insider purchases.

Help employers find you! Check out all the jobs and post your resume.

Back to news